GlobalRPh Renal Dosing Masterv6.6
Evidence addition

Hepatitis B vaccine - RECOMBIVAX HB Dialysis Formulation

Local RX List renal extractBase record retrieved 2026-09-07See the evidence for this drug2 sources available - open source summaries, references and comparisons

RECOMBIVAX HB dialysis

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

1 additional source qualifications - review before use
Dialysis vaccine dose counts and volumes are not interchangeable

RECOMBIVAX HB dialysis formulation and ENGERIX-B both use a high-dose adult approach, but their concentrations, injection volumes and series schedules differ. CDC directs readers to each product insert.

Before applying: Verify actual vaccine, formulation, prior doses and anti-HBs follow-up. Do not convert one product's volume or three-dose schedule into the other product's regimen.

Also check: Dialysis vaccine dose counts and volumes are not interchangeable

Rxlist source

GlobalRPh RX List - RECOMBIVAX HB dialysis

Product / population
IM RECOMBIVAX HB 40 mcg/mL dialysis formulation; adults >=18 years
Renal measure
Predialysis/dialysis adult vaccine population; anti-HBs monitoring

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Renal dosing, restrictions and evidence limits

For adult predialysis or dialysis patients, the dialysis formulation contains 40 mcg in 1 mL. Give three IM doses at months 0, 1 and 6. This is not the standard 10-mcg adult formulation. The dialysis formulation is approved for adults at least 18 years old; pediatric dialysis safety/effectiveness have not been established.

Consider booster vaccination or revaccination if anti-HBs is below 10 mIU/mL one to two months after dose three. Assess antibody levels annually and give a booster if they fall below 10 mIU/mL. Apply the full vaccination history and current immunization policy, not a renal drug-reduction algorithm.

Source revision: April 2023 | Retrieved: 2026-09-07. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/recombivax-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

GlobalRPh RX List

GlobalRPh RX List - RECOMBIVAX HB dialysis

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

IM RECOMBIVAX HB 40 mcg/mL dialysis formulation; adults >=18 years

Renal method: Predialysis/dialysis adult vaccine population; anti-HBs monitoring
Retrieved: 2026-09-07

Read local renal resultOpen original reference
Professional guidance

CDC hepatitis B vaccination - adult hemodialysis

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Adult hepatitis B vaccination in hemodialysis; product-specific schedules remain separate

Renal method: Adult hemodialysis vaccine population
Retrieved: 2026-09-07

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

product schedule difference

Dialysis vaccine dose counts and volumes are not interchangeable

RECOMBIVAX HB dialysis formulation and ENGERIX-B both use a high-dose adult approach, but their concentrations, injection volumes and series schedules differ. CDC directs readers to each product insert.

How to use this: Verify actual vaccine, formulation, prior doses and anti-HBs follow-up. Do not convert one product's volume or three-dose schedule into the other product's regimen.

GlobalRPh RX List - RECOMBIVAX HB dialysisCDC hepatitis B vaccination - adult hemodialysisHepatitis B vaccine - ENGERIX-B hemodialysis regimen

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeGlobalRPh RX List - RECOMBIVAX HB dialysisCDC hepatitis B vaccination - adult hemodialysis
Choose two source checkboxes below.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Exact product and population

Product identity selected for the separately displayed source protocols below. Reference: https://globalrph.com/rx-list/recombivax-drug/

Exact product and population

IM RECOMBIVAX HB 40 mcg/mL dialysis formulation; adults >=18 years

RDM38-SCOPE-hepatitis-b-vaccine-recombivax-dialysis · Source section: Selected source product scopeRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - RECOMBIVAX HB dialysis

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · IM RECOMBIVAX HB 40 mcg/mL dialysis formulation; adults >=18 years

Renal method: Predialysis/dialysis adult vaccine population; anti-HBs monitoring
Source date: April 2023
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

For adult predialysis or dialysis patients, the dialysis formulation contains 40 mcg in 1 mL. Give three IM doses at months 0, 1 and 6. This is not the standard 10-mcg adult formulation. The dialysis formulation is approved for adults at least 18 years old; pediatric dialysis safety/effectiveness have not been established.

Consider booster vaccination or revaccination if anti-HBs is below 10 mIU/mL one to two months after dose three. Assess antibody levels annually and give a booster if they fall below 10 mIU/mL. Apply the full vaccination history and current immunization policy, not a renal drug-reduction algorithm.

RDM38-rxlist-hepatitis-b-vaccine-recombivax-dialysis-6bdc0eceb6-C1 · Source locator: Dosage and schedule; booster vaccinations; pediatric use

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/recombivax-drug/
Retrieved
2026-09-07
Renal-function method
Predialysis/dialysis adult vaccine population; anti-HBs monitoring
Source date/version
April 2023
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
1764335347b5ec4db4623424a2fe404a71ec74e7d4f5d6fbab80440b2f6ce6e4
Separate professional-source layer

University and professional protocols

Professional

CDC hepatitis B vaccination - adult hemodialysis

Open original reference

Open / share this exact local source

CDC · Adult hepatitis B vaccination in hemodialysis; product-specific schedules remain separate

Renal method: Adult hemodialysis vaccine population
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

CDC advises high-dose (40 mcg) ENGERIX-B or RECOMBIVAX HB for adults receiving hemodialysis who need hepatitis B vaccination and directs clinicians to the individual package insert for the complete schedule. This supports the high-dose approach but does not make the products' volumes or dose counts interchangeable.

Use the product-specific local source card, the patient's vaccine history and the complete current immunization guidance. This selected CDC section is not a pediatric dialysis schedule.

RDM38-professional-hepatitis-b-vaccine-recombivax-dialysis-19f2c1d287-C1 · Source locator: Hepatitis B vaccine administration: Hemodialysis

Source identity and provenance
Source family
professional_guidance
Source
https://www.cdc.gov/hepatitis-b/hcp/vaccine-administration/index.html
Retrieved
2026-09-07
Renal-function method
Adult hemodialysis vaccine population
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
45e5650899424cf321bd52e94cfcbc72c478cb1cfd797dab6416896af5751196

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 1 RX List, 1 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/rx-list/recombivax-drug/
Source retrieval
2026-09-07. This is not the source publication or label revision date.
Original source type
rxlist summary
Local text SHA-256
b6598d62d88e958b66c6da634d70dacfabc180692a0f5b54ec021c71162247fd
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.

Read the full coverage report